Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Faissner

Showing results (21-30 of 82) with videos related to

Pageof 9
Sort By:
Therapeutic Advances in Neurological Disorders|November 6, 2014
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected casesRobert Hoepner, Simon Faissner, Gisa Ellrichmann, et al.
Journal of Neurology|October 31, 2023
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatmentSilvia R Delgado, Simon Faissner, Ralf A Linker, et al.
Pediatric Neurology|September 21, 2020
Delayed Diagnosis of Anti-Hu Antibodies in a Young Patient With Cerebellar AtrophyDaniel Richter, Tobias Hegelmaier, Christiane Schneider-Gold, et al.
Neurology|April 30, 2014
Teaching NeuroImages: sonographic "retrobulbar spot sign" in differentiating etiologies of sudden visual lossSimon Faissner, Christine Grunwald, Saskia H Meves, et al.
Journal of Neurology|August 26, 2021
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitisSimon Faissner, Daniel Richter, Ulas Ceylan, et al.
Neurological Research and Practice|December 16, 2020
General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNSIlya Ayzenberg, Simon Faissner, Laura Tomaske, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 5, 2020
Endocarditis following ocrelizumab in relapsing-remitting MSSimon Faissner, Carolin Schwake, Michael Gotzmann, et al.
Cells|February 25, 2023
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal EncephalomyelitisÜmmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Robert Hoepner, Carsten Lukas, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
Immunoadsorption in patients with neuromyelitis optica spectrum disorderSimon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Pageof 9

Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Therapeutic Advances in Neurological Disorders|November 6, 2014
Rituximab postprogressive multifocal leukoencephalopathy: a Feasible therapeutic option in selected casesRobert Hoepner, Simon Faissner, Gisa Ellrichmann, et al.
Journal of Neurology|October 31, 2023
Key characteristics of anti-CD20 monoclonal antibodies and clinical implications for multiple sclerosis treatmentSilvia R Delgado, Simon Faissner, Ralf A Linker, et al.
Pediatric Neurology|September 21, 2020
Delayed Diagnosis of Anti-Hu Antibodies in a Young Patient With Cerebellar AtrophyDaniel Richter, Tobias Hegelmaier, Christiane Schneider-Gold, et al.
Neurology|April 30, 2014
Teaching NeuroImages: sonographic "retrobulbar spot sign" in differentiating etiologies of sudden visual lossSimon Faissner, Christine Grunwald, Saskia H Meves, et al.
Journal of Neurology|August 26, 2021
COVID-19 mRNA vaccine induced rhabdomyolysis and fasciitisSimon Faissner, Daniel Richter, Ulas Ceylan, et al.
Neurological Research and Practice|December 16, 2020
General principles and escalation options of immunotherapy in autoantibody-associated disorders of the CNSIlya Ayzenberg, Simon Faissner, Laura Tomaske, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 5, 2020
Endocarditis following ocrelizumab in relapsing-remitting MSSimon Faissner, Carolin Schwake, Michael Gotzmann, et al.
Cells|February 25, 2023
Prophylactic Glatiramer Acetate Treatment Positively Attenuates Spontaneous Opticospinal EncephalomyelitisÜmmügülsüm Koc, Steffen Haupeltshofer, Katharina Klöster, et al.
Therapeutic Advances in Neurological Disorders|November 12, 2015
Tumefactive multiple sclerosis lesions in two patients after cessation of fingolimod treatmentSimon Faissner, Robert Hoepner, Carsten Lukas, et al.
Therapeutic Advances in Neurological Disorders|July 2, 2016
Immunoadsorption in patients with neuromyelitis optica spectrum disorderSimon Faissner, Johanna Nikolayczik, Andrew Chan, et al.
Pageof 9